Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 24 peer-reviewed journal articles Updated
Pediatric Dermatology

Long-Term Care: Navigating Life After the NICU

At a Glance

After NICU discharge, babies with neonatal erythroderma, autoinflammation, and very-early-onset inflammatory bowel disease need an individualized plan for skin and gut care, nutrition, infection prevention, immune monitoring, and specialist follow-up; caregivers also need support for medical trauma.

Moving from the highly monitored environment of the NICU to home care is a major milestone, but it often brings a new set of anxieties. For a baby with erythroderma, autoinflammation, and VEO-IBD, home care is about creating a stable, clinical environment where your baby can grow while the immune system is carefully managed [1][2].

Individualized Daily Skin and Gut Management

At home, you become the primary provider of the care that was once done by nurses. This should be guided by a detailed, written discharge plan provided by your specialists.

  • The Bathing Routine: Standard care for post-erythrodermic skin often involves specific bathing regimens. Your dermatologist must dictate the frequency and use of pH-balanced cleansers based on whether the skin is intact, weeping, or infected [3].
  • Topical Care: You may apply prescribed emollients or barrier creams. Do not change topical regimens without calling the team, as inappropriate products can harm fragile skin [4][5].
  • Feeding and Nutrition: Depending on the gut’s function, your baby may require a specialized elemental formula [6][7]. If feeding or aspiration problems occur, a G-tube (gastrostomy tube) may be used to deliver nutrition to the stomach [8].
  • Growth Tracking: You will monitor “ins and outs”—carefully tracking feeding volumes and stool characteristics [9].

Infection Prevention at Home

If your baby has an underlying immunodeficiency, infection prevention is paramount.

  • The “Cocoon” Strategy: Your team will provide specific advice on ensuring visitors and household members are appropriately vaccinated and practice strict handwashing [10].
  • Vaccine Restrictions: Live attenuated vaccines (like Rotavirus or, when older, MMR) are restricted depending on the specific immune defect, immune recovery, and transplant status. Do not delay or administer vaccines without the immunology team’s written plan [11][12]. Routine inactivated vaccines are generally encouraged but must be timed appropriately.
  • Hand Hygiene: Strict handwashing is the simplest and most effective way to prevent the introduction of common viruses [10].

Your Surveillance Schedule

Ongoing monitoring is vital. Because your infant’s status—whether stable, receiving biologics, on TPN, or post-transplant—dictates their needs, the surveillance schedule will be highly individualized.

While every baby is different, your schedule may include checks on growth and nutrition [9], blood chemistry and inflammatory markers [13][14], immune function tests like flow cytometry [15][16], and specialty reviews by dermatology or GI [17][18]. Follow your personalized discharge schedule strictly.

The Psychological Toll on Caregivers

Caring for a child with a rare, life-threatening condition is a form of sustained trauma. It is common for parents to experience post-traumatic stress symptoms, which can manifest as “scanxiety” (intense anxiety before tests), flashbacks to the NICU, or a constant state of hyper-vigilance [19][20].

Research shows that parents of critically ill infants frequently experience these symptoms [21][22]. Acknowledging that your mental health is as important as your baby’s physical health is the first step toward healing. Routine screening is encouraged, and many families find that trauma-focused therapy or connecting with rare-disease support groups provides a vital lifeline [23][2]. Your medical team should refer you to psychological support [24].

Common questions in this guide

What skin care does my baby need at home after leaving the NICU?
Use the written discharge plan from your specialists. It may specify how often to bathe, which pH-balanced cleanser to use, and when to apply prescribed moisturizers or barrier creams. Do not change skin-care products or routines without contacting the care team.
How should I track my baby’s feeding, stools, and growth at home?
Track feeding volumes, wet diapers and stools, stool frequency and appearance, medications, and skin changes as directed. These details help specialists identify a possible flare, feeding problem, or growth concern. Your team should explain what is normal for your baby and which changes require a call.
Can my baby receive routine vaccines with an immune problem?
Live vaccines such as rotavirus and, later, MMR may be restricted depending on the immune defect, immune recovery, and transplant status. Do not start, delay, or schedule vaccines without a written plan from the immunology team. Household members and visitors may also be asked to stay vaccinated and practice careful hand hygiene.
What follow-up tests and specialist visits will my baby need?
Follow-up is individualized and may include growth and nutrition checks, blood chemistry, inflammatory markers, immune-function testing such as flow cytometry, and dermatology or gastroenterology visits. The schedule may depend on whether your baby is stable, receiving biologic treatment, on TPN, or post-transplant. Follow the discharge schedule even when your baby seems well.
When might a G-tube be considered for my baby?
A G-tube may be considered when oral feeding is not safe or sufficient, when aspiration is a concern, or when growth begins to plateau. It delivers formula or other nutrition directly to the stomach. The decision should be made with your baby’s feeding, gastroenterology, and nutrition teams.
How can caregivers get help after a traumatic NICU experience?
Hypervigilance, poor sleep, flashbacks, and intense anxiety before tests can occur after a traumatic NICU experience. Ask the medical team for routine screening and a referral to trauma-focused therapy or a rare-disease support group. Getting help for your mental health is part of caring for your family.
What should we do if our baby develops a fever at home?
Ask for a written fever plan before discharge because infection risk and emergency needs can be individualized. The plan should identify which emergency department to use and which specialist team should be contacted or paged. Keep it accessible and follow it if your baby develops a fever or other urgent symptoms.

Get notified when new evidence is published on Neonatal erythroderma-autoinflammation-inflammatory bowel disease syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (24)
  1. 1

    North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Position Paper on the Evaluation and Management for Patients With Very Early-onset Inflammatory Bowel Disease.

    Kelsen JR, Sullivan KE, Rabizadeh S, et al.

    Journal of pediatric gastroenterology and nutrition 2020; (70(3)):389-403 doi:10.1097/MPG.0000000000002567.

    PMID: 32079889
  2. 2

    Very Early-Onset Inflammatory Bowel Disease: A Challenging Field for Pediatric Gastroenterologists.

    Arai K

    Pediatric gastroenterology, hepatology & nutrition 2020; (23(5)):411-422 doi:10.5223/pghn.2020.23.5.411.

    PMID: 32953636
  3. 3

    Neonatal Erythroderma: Diagnostic Challenges and the Limitations of Genetic Testing.

    Phipps J, Popescu O

    Cureus 2025; (17(11)):e96134 doi:10.7759/cureus.96134.

    PMID: 41357000
  4. 4

    Netherton Syndrome in a preterm newborn presenting with erythroderma and temperature instability: a case report.

    Rossos AEM, Levy R, Ansari NS

    BMC pediatrics 2026; (26(1)).

    PMID: 41981412
  5. 5

    Erythroderma (exfoliative dermatitis). Part 2: energy homeostasis and dietetic management strategies.

    Tso S, Moiz H, Satchwell F, et al.

    Clinical and experimental dermatology 2021; (46(6)):1011-1015 doi:10.1111/ced.14667.

    PMID: 33817816
  6. 6

    Nutritional Approach in Pediatric Patients with Inflammatory Bowel Disease: Treatment, Risk and Challenges.

    Capra ME, Bellani AM, Berzieri M, et al.

    Nutrients 2025; (17(22)) doi:10.3390/nu17223545.

    PMID: 41305596
  7. 7

    Nutritional Therapy in Very Early-Onset Inflammatory Bowel Disease: A Case Report.

    Miller TL, Lee D, Giefer M, et al.

    Digestive diseases and sciences 2017; (62(8)):2196-2200 doi:10.1007/s10620-017-4616-9.

    PMID: 28551707
  8. 8

    Clinical Phenotypes and Outcomes in Monogenic Versus Non-monogenic Very Early Onset Inflammatory Bowel Disease.

    Collen LV, Kim DY, Field M, et al.

    Journal of Crohn's & colitis 2022; (16(9)):1380-1396 doi:10.1093/ecco-jcc/jjac045.

    PMID: 35366317
  9. 9

    Basic anthropometry, micronutrients status and growth velocity of patients with early-onset inflammatory bowel disease: A prospective cohort study.

    El Koofy NM, Moawad EMI, Yassin NA, et al.

    Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology 2022; (23(4)):270-276 doi:10.1016/j.ajg.2022.06.004.

    PMID: 35918289
  10. 10

    Positive Newborn Screening for Severe Combined Immunodeficiency: What Should the Pediatrician Do?

    Mongkonsritragoon W, Huang J, Fredrickson M, et al.

    Clinical medicine insights. Pediatrics 2023; (17()):11795565231162839 doi:10.1177/11795565231162839.

    PMID: 37025258
  11. 11

    Guidelines for Screening, Early Diagnosis and Management of Severe Combined Immunodeficiency (SCID) in India.

    Madkaikar M, Aluri J, Gupta S

    Indian journal of pediatrics 2016; (83(5)):455-62 doi:10.1007/s12098-016-2059-5.

    PMID: 26920398
  12. 12

    Newborn screening for severe combined immunodeficiency-Coming to a region near you soon.

    Elliman DAC, Gennery AR

    Clinical and experimental immunology 2021; (205(3)):343-345 doi:10.1111/cei.13642.

    PMID: 34235744
  13. 13

    The Value of Serum Amyloid A Levels in Familial Mediterranean Fever to Identify Occult Inflammation During Asymptomatic Periods.

    Çakan M, Karadağ ŞG, Tanatar A, et al.

    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2021; (27(1)):1-4 doi:10.1097/RHU.0000000000001134.

    PMID: 31524848
  14. 14

    Infantile and Very Early Onset Inflammatory Bowel Disease: A Multicenter Study.

    Guz-Mark A, Aloi M, Scarallo L, et al.

    Pediatrics 2024; (154(2)) doi:10.1542/peds.2023-064546.

    PMID: 39015095
  15. 15

    Genomic testing identifies monogenic causes in patients with very early-onset inflammatory bowel disease: a multicenter survey in an Iranian cohort.

    Eslamian G, Jamee M, Momen T, et al.

    Clinical and experimental immunology 2024; (217(1)):1-11 doi:10.1093/cei/uxae037.

    PMID: 38651248
  16. 16

    Diagnostic utility of targeted flow cytometry in genetically confirmed inborn errors of immunity: a 20-year single-center experience.

    Soyöz Ö, Çelebi Çelik F, Kaya MŞ, et al.

    Frontiers in immunology 2026; (17()):1940152 doi:10.3389/fimmu.2026.1940152.

    PMID: 42851642
  17. 17

    From Genes to Gut: Understanding Diagnosis and Treatment in Very Early Onset Inflammatory Bowel Disease.

    Konys C, Usman Y, Runde J

    Pediatric annals 2025; (54(8)):e280-e285 doi:10.3928/19382359-20250612-04.

    PMID: 40772941
  18. 18

    Proposal of Slovenian guidelines for the diagnosis of neonatal erythroderma with a case report of Omenn syndrome.

    Starbek Zorko M, Štublar Krašovec A, Dragoš V

    Acta dermatovenerologica Alpina, Pannonica, et Adriatica 2023; (32(2)):57-61.

    PMID: 37365893
  19. 19

    The Prevalence of PTSD of Mothers and Fathers of High-Risk Infants Admitted to NICU: A Systematic Review.

    McKeown L, Burke K, Cobham VE, et al.

    Clinical child and family psychology review 2023; (26(1)):33-49 doi:10.1007/s10567-022-00421-4.

    PMID: 36564614
  20. 20

    Post-traumatic stress disorder specific to parents in the neonatal intensive care unit.

    McKeown L, Pervin S, Burke K, et al.

    Australian critical care : official journal of the Confederation of Australian Critical Care Nurses 2025; (38(4)):101257 doi:10.1016/j.aucc.2025.101257.

    PMID: 40435764
  21. 21

    Risk factors and preventive strategies for post-traumatic stress disorder in neonatal intensive care unit.

    Di Chiara M, Laccetta G, Gangi S, et al.

    Frontiers in psychology 2022; (13()):1003566 doi:10.3389/fpsyg.2022.1003566.

    PMID: 36438350
  22. 22

    Psychological Outcomes in Families of PICU Survivors: A Meta-Analysis.

    Ko MSM, Lee WK, Sultana R, et al.

    Pediatrics 2024; (154(1)) doi:10.1542/peds.2023-064210.

    PMID: 38916047
  23. 23

    Group Psychotherapy for Parents of Youth with Pediatric Acute-Onset Neuropsychiatric Syndrome.

    Ellerkamp H, Thienemann M, Tinero J, et al.

    Journal of clinical psychology in medical settings 2023; (30(3)):660-672 doi:10.1007/s10880-022-09926-0.

    PMID: 36480109
  24. 24

    Effects of psychosocial interventions on emotional health outcomes in parents within one year after paediatric intensive care: A systematic review and meta-analysis.

    Matsuishi Y, Manning JC, Ikeda M, et al.

    Intensive & critical care nursing 2026; (98()):104580 doi:10.1016/j.iccn.2026.104580.

    PMID: 42790387

This page provides general information about long-term home care after NICU discharge for a baby with neonatal erythroderma-autoinflammation-inflammatory bowel disease syndrome. It is for informational purposes only and does not constitute medical advice; follow the individualized plan from your baby’s dermatology, gastroenterology, and immunology teams.

Guide contents Neonatal erythroderma-autoinflammation-inflammatory bowel disease syndrome
Research & Literature
06 Building Your Care Team